Pharmaceutical Business Review
Return to: PBR Home | Companies

Achillion Pharmaceuticals Inc

Achillion Pharmaceuticals Inc
300 George Street
New Haven
United States of America
Phone: 1 203 6247000
Fax: 12-03-6247003
www.achillion.com

No. employees: 81
Turnover: 15.00 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Milind S. Deshpande, Ph.D.

Director, Chief Executive Officer, President, Executive Board

David I. Scheer

Chairman, Executive Board

Gary E. Frashier

Director, Non Executive Board

Jason S. Fisherman, M.D.

Director, Non Executive Board

Robert L. Van Nostrand

Director, Non Executive Board

Michael D. Kishbauch

Director, Non Executive Board

Kurt Graves

Director, Non Executive Board

Nicole Vitullo

Director, Non Executive Board

Frank Verwiel M.D.

Director, Non Executive Board

Joseph Truitt

Chief Operating Officer, Senior Management

Mary Kay Fenton

Executive Vice President, Chief Financial Officer, Senior Management

David Apelian, M.D., Ph.D.

Executive Vice President, Chief Medical Officer, Senior Management

Joel Barrish, Ph.D.

Chief Scientific Officer, Executive Vice President, Senior Management

Michael Banks, Ph.D.

Senior Vice President - Pharmaceutical Sciences, Senior Management

Ky Nam-Wortman

Vice President - Head of Human Resources, Senior Management

Maira Rieger

Vice President - Portfolio Management, Senior Management

Martha Manning

Executive Vice President, General Counsel, Secretary, Senior Management

Amy Jennings, Ph.D.

Senior Vice President - Regulatory Affairs, Senior Management

Locations/Subsidiaries


300 George Street,
New Haven,
Connecticut,
United States of America
Phone: 1 203 6247000
Fax: 1 203 6247003

Products/Services


Products:

  • Pipeline
  • ACH-4471- Paroxysmal Nocturnal Hemoglobinuria
  • Factor D Inhibitors:
  • Dry Age-related Macular Degeneration
  • Chronic Obstructive Pulmonary Disease
  • C3 Glomerulopathy
  • Resistant Bacterial Infections:
  • ACH-702
  • HIV Infection:
  • Elvucitabine
  • Janssen Collaboration:
  • HCV Triple Regimen
  • Odalasvir - Hepatitis C
  • ACH-3422 - Hepatitis C
  • Sovaprevir - Hepatitis C